C21 Investments (XCNQ:CXXI) Debt-to-Equity

: 0.30 (As of Oct. 2023)

View and export this data going back to 1987. Start your Free Trial

C21 Investments's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Oct. 2023 was C$2.22 Mil. C21 Investments's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Oct. 2023 was C$11.25 Mil. C21 Investments's Total Stockholders Equity for the quarter that ended in Oct. 2023 was C$45.36 Mil. C21 Investments's debt to equity for the quarter that ended in Oct. 2023 was 0.30.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for C21 Investments's Debt-to-Equity or its related term are showing as below:

XCNQ:CXXI' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.13 Med: 0.63 Max: 2.66
Current: 0.3

During the past 13 years, the highest Debt-to-Equity Ratio of C21 Investments was 2.66. The lowest was 0.13. And the median was 0.63.

XCNQ:CXXI's Debt-to-Equity is ranked worse than
50.88% of 855 companies
in the Drug Manufacturers industry
Industry Median: 0.29 vs XCNQ:CXXI: 0.30

C21 Investments Debt-to-Equity Historical Data

The historical data trend for C21 Investments's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C21 Investments Annual Data

Trend

Jan14

Jan15

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Debt-to-Equity

2.37

2.66

1.12

0.55

0.35

C21 Investments Quarterly Data
	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23
Debt-to-Equity																0.37	0.35	0.33	0.30	0.30

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, C21 Investments's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

C21 Investments Debt-to-Equity Distribution

For the Drug Manufacturers industry and Healthcare sector, C21 Investments's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where C21 Investments's Debt-to-Equity falls into.

C21 Investments Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

C21 Investments's Debt to Equity Ratio for the fiscal year that ended in Jan. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(4.808	+	11.483)	/	46.058
	=	0.35

C21 Investments's Debt to Equity Ratio for the quarter that ended in Oct. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2.216	+	11.245)	/	45.358
	=	0.30

C21 Investments (XCNQ:CXXI) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

C21 Investments Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of C21 Investments's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

C21 Investments (XCNQ:CXXI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » C21 Investments Inc (XCNQ:CXXI) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

CXXIF:USA

Address

601 West Cordova Street, Suite 280, Vancouver, BC, CAN, V6B 1G1

Website

https://www.cxxi.ca

C21 Investments Inc is a vertically integrated cannabis company. It cultivates, processes, manufactures, and distributes cannabis and hemp-derived consumer products. C21's focus is to expand where the company can wholly own indoor or outdoor cultivation operations, extraction facilities, bakeries, branded products, and retail dispensaries with a large distribution network.

C21 Investments (XCNQ:CXXI) Headlines

No Headlines